BMJ Round Table Shared Decision - Making Practicalities

BMJ Round Table Shared Decision - Making Practicalities

Author: The BMJ August 28, 2013 Duration: 23:31

At BMA house, we convened a group of world experts in shared decision making. Inspired by the Salzburg Global Summit meeting we discussed the background, practical challenges, and how to engage patients with their health

The participants were:

Fiona Godlee , editor in chief, BMJ

Angela Coulter , director of global initiatives, Foundation for Informed Medical Decision Making

Albert Mulley , co-founder, Foundation for Informed Medical Decision Making, and director, Dartmouth Center for Health Care Delivery Science

Glyn Elwyn, research professor with an interest in shared decision making, Cardiff University

Muir Gray , chair of the Information Standard, Department of Health, and co-editor (with Gerd Gigerenzer of the new book Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020

Marion Collict, national programme manager, shared decision making, NHS (UK’s National Health System)

Alf Collins , consultant in pain medicine, Taunton and Somerset NHS Foundation Trust, and national clinical lead for Co-Creating Health

Margaret McCartney , writer and GP

Anu Dhir , junior surgical trainee and co-signatory of the Salzburg Statement

Gerd Gigerenzer , director, Center for Adaptive Behaviour and Cognition, Max Planck Institute for Human Behaviour

Lisa Schwartz , professor of medicine, Dartmouth Medical School, author (with Steve Woloshin (see below)) of Know Your Chances available free online.

Steve Woloshin , professor of medicine, Dartmouth Medical School

“e-Patient Dave” deBronkart , co-chair, Society for Participatory Medicine

Tessa Richards , analysis editor, BMJ

Sue Ziebland , research director of the Health Experiences Research Group and a reader in qualitative health research, Department of Primary Health Care, University of Oxford


Produced by The BMJ, this weekly audio series delves into the pivotal research and urgent clinical debates shaping modern medicine. Each episode moves beyond the published page, bringing together the authors, critics, and practitioners directly involved to dissect a new study or a pressing health question. The conversation is rigorous and nuanced, designed for those who appreciate the complexity behind headlines. You’ll hear unscripted discussion about methodology, implications for practice, and the occasional healthy disagreement that drives science forward. This isn't just a summary of the latest findings; it's a critical appraisal in real time, offering listeners a front-row seat to the evolving discourse that defines evidence-based care. The Medicine and Science from The BMJ podcast serves as an essential audio companion for clinicians, academics, and anyone keen to understand the ‘why’ and ‘how’ behind medical news. It transforms the latest evidence from the journal into an accessible, thought-provoking dialogue, ensuring that busy professionals can stay deeply informed. Tune in for a direct, intelligent, and often surprising take on the science that matters most.
Author: Language: English Episodes: 1000

Medicine and Science from The BMJ
Podcast Episodes
Should we scrap the internal market in England’s NHS [not-audio_url] [/not-audio_url]

Duration: 18:47
The "internal market" was created after the 1987 UK general election focused attention on inadequate funding in the NHS, long waiting lists for elective surgery, and large unwarranted variations in clinical care. Economi…
Treating hip osteoarthritis [not-audio_url] [/not-audio_url]

Duration: 23:40
2.46 million people in England have osteoarthritis of the hip, and many of those go on to eventually have a hip replacement - which is now widely considered one of the most commonly performed and successful operations in…
Having hip osteoarthritis [not-audio_url] [/not-audio_url]

Duration: 12:42
2.46 million people in England have osteoarthritis of the hip, and many of those go on to eventually have a hip replacement - which is now widely considered one of the most commonly performed and successful operations in…
PreP And public health [not-audio_url] [/not-audio_url]

Duration: 17:03
The drug Truvada, licenced for HIV PrEP, costs £350 a month but is shown to be cost effective in preventing infection. However, in the English NHS, a row has broken out about which body should fund the treatment - NHS En…
Epilepsy in pregnancy [not-audio_url] [/not-audio_url]

Duration: 17:32
In every 1000 pregnancies, between two and five infants are born to women with epilepsy. For such women, pregnancy can be a time of anxiety over maternal and fetal wellbeing. In 96% of pregnancies they will deliver a hea…
Caring for patients with delirium at the end of their life [not-audio_url] [/not-audio_url]

Duration: 18:17
Delirium is common in the last weeks or days of life. It can be distressing for patients and those around them. A clinical update explains why successful management involves excluding reversible causes of delirium and ba…